nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CYP1A1—polycystic ovary syndrome	0.429	1	CbGaD
Diclofenac—TTR—urine—polycystic ovary syndrome	0.0077	0.0471	CbGeAlD
Diclofenac—UGT1A1—urine—polycystic ovary syndrome	0.0073	0.0447	CbGeAlD
Diclofenac—PTGS2—ovarian follicle—polycystic ovary syndrome	0.0064	0.0392	CbGeAlD
Diclofenac—CXCR1—adipose tissue—polycystic ovary syndrome	0.00607	0.0371	CbGeAlD
Diclofenac—Tooth abscess—Metformin—polycystic ovary syndrome	0.00564	0.0445	CcSEcCtD
Diclofenac—Sinus congestion—Metformin—polycystic ovary syndrome	0.00474	0.0373	CcSEcCtD
Diclofenac—Appetite absent—Metformin—polycystic ovary syndrome	0.00474	0.0373	CcSEcCtD
Diclofenac—SLC22A8—urine—polycystic ovary syndrome	0.00472	0.0289	CbGeAlD
Diclofenac—Mefenamic acid—AKR1C2—polycystic ovary syndrome	0.00446	0.317	CrCbGaD
Diclofenac—Azotaemia—Metformin—polycystic ovary syndrome	0.00442	0.0348	CcSEcCtD
Diclofenac—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00401	0.0316	CcSEcCtD
Diclofenac—CYP2C19—urine—polycystic ovary syndrome	0.00396	0.0242	CbGeAlD
Diclofenac—Toothache—Metformin—polycystic ovary syndrome	0.00387	0.0305	CcSEcCtD
Diclofenac—Nail disorder—Metformin—polycystic ovary syndrome	0.00363	0.0286	CcSEcCtD
Diclofenac—ASIC1—adipose tissue—polycystic ovary syndrome	0.00361	0.0221	CbGeAlD
Diclofenac—Heartburn—Metformin—polycystic ovary syndrome	0.00343	0.027	CcSEcCtD
Diclofenac—ASIC1—adrenal gland—polycystic ovary syndrome	0.00324	0.0198	CbGeAlD
Diclofenac—CYP1A2—urine—polycystic ovary syndrome	0.00323	0.0198	CbGeAlD
Diclofenac—CYP2C9—urine—polycystic ovary syndrome	0.00307	0.0188	CbGeAlD
Diclofenac—ASIC1—female gonad—polycystic ovary syndrome	0.00302	0.0185	CbGeAlD
Diclofenac—CYP2E1—urine—polycystic ovary syndrome	0.00291	0.0178	CbGeAlD
Diclofenac—ASIC1—endocrine gland—polycystic ovary syndrome	0.00281	0.0172	CbGeAlD
Diclofenac—PLA2G2A—adrenal cortex—polycystic ovary syndrome	0.0027	0.0165	CbGeAlD
Diclofenac—Contusion—Metformin—polycystic ovary syndrome	0.0027	0.0213	CcSEcCtD
Diclofenac—CXCL8—adrenal cortex—polycystic ovary syndrome	0.00268	0.0164	CbGeAlD
Diclofenac—Accidental injury—Metformin—polycystic ovary syndrome	0.00266	0.021	CcSEcCtD
Diclofenac—KCNQ2—pituitary gland—polycystic ovary syndrome	0.00265	0.0162	CbGeAlD
Diclofenac—TTR—embryo—polycystic ovary syndrome	0.00249	0.0152	CbGeAlD
Diclofenac—Mefenamic acid—AKR1C1—polycystic ovary syndrome	0.00244	0.174	CrCbGaD
Diclofenac—PLA2G2A—endometrium—polycystic ovary syndrome	0.00241	0.0148	CbGeAlD
Diclofenac—CXCL8—endometrium—polycystic ovary syndrome	0.00239	0.0146	CbGeAlD
Diclofenac—CYP3A4—urine—polycystic ovary syndrome	0.00234	0.0143	CbGeAlD
Diclofenac—KCNQ2—female gonad—polycystic ovary syndrome	0.00221	0.0135	CbGeAlD
Diclofenac—PLA2G2A—pituitary gland—polycystic ovary syndrome	0.00218	0.0134	CbGeAlD
Diclofenac—PLA2G2A—adipose tissue—polycystic ovary syndrome	0.00218	0.0133	CbGeAlD
Diclofenac—CXCL8—pituitary gland—polycystic ovary syndrome	0.00216	0.0132	CbGeAlD
Diclofenac—CXCL8—adipose tissue—polycystic ovary syndrome	0.00215	0.0132	CbGeAlD
Diclofenac—Lightheadedness—Metformin—polycystic ovary syndrome	0.00211	0.0166	CcSEcCtD
Diclofenac—KCNQ2—endocrine gland—polycystic ovary syndrome	0.00205	0.0126	CbGeAlD
Diclofenac—Ear pain—Metformin—polycystic ovary syndrome	0.00201	0.0158	CcSEcCtD
Diclofenac—PLA2G2A—adrenal gland—polycystic ovary syndrome	0.00195	0.0119	CbGeAlD
Diclofenac—CXCL8—adrenal gland—polycystic ovary syndrome	0.00193	0.0118	CbGeAlD
Diclofenac—Injury—Metformin—polycystic ovary syndrome	0.00186	0.0147	CcSEcCtD
Diclofenac—SLCO1C1—pituitary gland—polycystic ovary syndrome	0.00184	0.0113	CbGeAlD
Diclofenac—SLCO1C1—adipose tissue—polycystic ovary syndrome	0.00184	0.0112	CbGeAlD
Diclofenac—Meclofenamic acid—AKR1C3—polycystic ovary syndrome	0.00182	0.13	CrCbGaD
Diclofenac—PLA2G2A—female gonad—polycystic ovary syndrome	0.00182	0.0111	CbGeAlD
Diclofenac—CXCL8—female gonad—polycystic ovary syndrome	0.0018	0.011	CbGeAlD
Diclofenac—Renal impairment—Metformin—polycystic ovary syndrome	0.0018	0.0142	CcSEcCtD
Diclofenac—CXCL8—vagina—polycystic ovary syndrome	0.00179	0.011	CbGeAlD
Diclofenac—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00175	0.0138	CcSEcCtD
Diclofenac—Lethargy—Metformin—polycystic ovary syndrome	0.00175	0.0138	CcSEcCtD
Diclofenac—Pain in extremity—Metformin—polycystic ovary syndrome	0.00171	0.0135	CcSEcCtD
Diclofenac—SCN4A—pituitary gland—polycystic ovary syndrome	0.0017	0.0104	CbGeAlD
Diclofenac—PLA2G2A—endocrine gland—polycystic ovary syndrome	0.00169	0.0104	CbGeAlD
Diclofenac—SCN4A—adipose tissue—polycystic ovary syndrome	0.00169	0.0103	CbGeAlD
Diclofenac—Migraine—Metformin—polycystic ovary syndrome	0.00168	0.0133	CcSEcCtD
Diclofenac—CYP2C18—vagina—polycystic ovary syndrome	0.00165	0.0101	CbGeAlD
Diclofenac—TTR—pituitary gland—polycystic ovary syndrome	0.00165	0.0101	CbGeAlD
Diclofenac—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00156	0.0123	CcSEcCtD
Diclofenac—CYP2C18—endocrine gland—polycystic ovary syndrome	0.00154	0.00945	CbGeAlD
Diclofenac—Cramp muscle—Metformin—polycystic ovary syndrome	0.00154	0.0121	CcSEcCtD
Diclofenac—Nasopharyngitis—Metformin—polycystic ovary syndrome	0.00153	0.0121	CcSEcCtD
Diclofenac—SCN4A—adrenal gland—polycystic ovary syndrome	0.00151	0.00927	CbGeAlD
Diclofenac—Abdominal distension—Metformin—polycystic ovary syndrome	0.00149	0.0117	CcSEcCtD
Diclofenac—ALOX5—adipose tissue—polycystic ovary syndrome	0.00149	0.00911	CbGeAlD
Diclofenac—Influenza—Metformin—polycystic ovary syndrome	0.00148	0.0116	CcSEcCtD
Diclofenac—Pancreatitis—Metformin—polycystic ovary syndrome	0.00145	0.0114	CcSEcCtD
Diclofenac—Clonidine—ADRA1D—polycystic ovary syndrome	0.00144	0.103	CrCbGaD
Diclofenac—Sweating increased—Metformin—polycystic ovary syndrome	0.00144	0.0113	CcSEcCtD
Diclofenac—Angina pectoris—Metformin—polycystic ovary syndrome	0.00144	0.0113	CcSEcCtD
Diclofenac—SLCO1C1—endocrine gland—polycystic ovary syndrome	0.00143	0.00874	CbGeAlD
Diclofenac—UGT2B7—endocrine gland—polycystic ovary syndrome	0.00142	0.00871	CbGeAlD
Diclofenac—Mefenamic acid—AKR1C3—polycystic ovary syndrome	0.00142	0.101	CrCbGaD
Diclofenac—Abdominal discomfort—Metformin—polycystic ovary syndrome	0.00142	0.0112	CcSEcCtD
Diclofenac—SLC22A11—endocrine gland—polycystic ovary syndrome	0.00139	0.00849	CbGeAlD
Diclofenac—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00137	0.0108	CcSEcCtD
Diclofenac—ALOX5—adrenal gland—polycystic ovary syndrome	0.00133	0.00817	CbGeAlD
Diclofenac—Infestation NOS—Metformin—polycystic ovary syndrome	0.00132	0.0104	CcSEcCtD
Diclofenac—Infestation—Metformin—polycystic ovary syndrome	0.00132	0.0104	CcSEcCtD
Diclofenac—Drowsiness—Metformin—polycystic ovary syndrome	0.00132	0.0104	CcSEcCtD
Diclofenac—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00129	0.0102	CcSEcCtD
Diclofenac—TTR—endocrine gland—polycystic ovary syndrome	0.00128	0.00782	CbGeAlD
Diclofenac—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00125	0.00982	CcSEcCtD
Diclofenac—ALOX5—female gonad—polycystic ovary syndrome	0.00124	0.00762	CbGeAlD
Diclofenac—Clonidine—ADRA1B—polycystic ovary syndrome	0.00123	0.0876	CrCbGaD
Diclofenac—UGT1A1—endocrine gland—polycystic ovary syndrome	0.00121	0.00741	CbGeAlD
Diclofenac—Bradycardia—Metformin—polycystic ovary syndrome	0.00121	0.00949	CcSEcCtD
Diclofenac—Rhinitis—Metformin—polycystic ovary syndrome	0.00119	0.00935	CcSEcCtD
Diclofenac—Hepatitis—Metformin—polycystic ovary syndrome	0.00118	0.00932	CcSEcCtD
Diclofenac—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00118	0.00928	CcSEcCtD
Diclofenac—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00117	0.00919	CcSEcCtD
Diclofenac—ALOX5—endocrine gland—polycystic ovary syndrome	0.00116	0.00708	CbGeAlD
Diclofenac—Eye disorder—Metformin—polycystic ovary syndrome	0.00111	0.00871	CcSEcCtD
Diclofenac—Cardiac disorder—Metformin—polycystic ovary syndrome	0.0011	0.00865	CcSEcCtD
Diclofenac—Flushing—Metformin—polycystic ovary syndrome	0.0011	0.00865	CcSEcCtD
Diclofenac—ABCC1—adrenal cortex—polycystic ovary syndrome	0.00108	0.00658	CbGeAlD
Diclofenac—Angiopathy—Metformin—polycystic ovary syndrome	0.00107	0.00846	CcSEcCtD
Diclofenac—Immune system disorder—Metformin—polycystic ovary syndrome	0.00107	0.00842	CcSEcCtD
Diclofenac—Mediastinal disorder—Metformin—polycystic ovary syndrome	0.00107	0.0084	CcSEcCtD
Diclofenac—Chills—Metformin—polycystic ovary syndrome	0.00106	0.00837	CcSEcCtD
Diclofenac—ABCC4—uterus—polycystic ovary syndrome	0.00104	0.00635	CbGeAlD
Diclofenac—Erythema—Metformin—polycystic ovary syndrome	0.00103	0.00812	CcSEcCtD
Diclofenac—Malnutrition—Metformin—polycystic ovary syndrome	0.00103	0.00812	CcSEcCtD
Diclofenac—Flatulence—Metformin—polycystic ovary syndrome	0.00102	0.008	CcSEcCtD
Diclofenac—ABCC4—adipose tissue—polycystic ovary syndrome	0.00101	0.00621	CbGeAlD
Diclofenac—Dysgeusia—Metformin—polycystic ovary syndrome	0.00101	0.00795	CcSEcCtD
Diclofenac—Muscle spasms—Metformin—polycystic ovary syndrome	0.000991	0.0078	CcSEcCtD
Diclofenac—Vision blurred—Metformin—polycystic ovary syndrome	0.000971	0.00765	CcSEcCtD
Diclofenac—Tremor—Metformin—polycystic ovary syndrome	0.000965	0.0076	CcSEcCtD
Diclofenac—ABCC1—endometrium—polycystic ovary syndrome	0.00096	0.00587	CbGeAlD
Diclofenac—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000956	0.00753	CcSEcCtD
Diclofenac—ALB—adrenal gland—polycystic ovary syndrome	0.00094	0.00575	CbGeAlD
Diclofenac—Malaise—Metformin—polycystic ovary syndrome	0.000929	0.00732	CcSEcCtD
Diclofenac—Syncope—Metformin—polycystic ovary syndrome	0.000924	0.00728	CcSEcCtD
Diclofenac—Palpitations—Metformin—polycystic ovary syndrome	0.000911	0.00717	CcSEcCtD
Diclofenac—ABCC4—adrenal gland—polycystic ovary syndrome	0.00091	0.00557	CbGeAlD
Diclofenac—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000906	0.00713	CcSEcCtD
Diclofenac—Hypertension—Metformin—polycystic ovary syndrome	0.00089	0.00701	CcSEcCtD
Diclofenac—ABCC1—uterus—polycystic ovary syndrome	0.000885	0.00541	CbGeAlD
Diclofenac—Myalgia—Metformin—polycystic ovary syndrome	0.000877	0.00691	CcSEcCtD
Diclofenac—Chest pain—Metformin—polycystic ovary syndrome	0.000877	0.00691	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.000871	0.00686	CcSEcCtD
Diclofenac—ABCC1—pituitary gland—polycystic ovary syndrome	0.000869	0.00532	CbGeAlD
Diclofenac—Discomfort—Metformin—polycystic ovary syndrome	0.000867	0.00683	CcSEcCtD
Diclofenac—PTGS2—embryo—polycystic ovary syndrome	0.000866	0.0053	CbGeAlD
Diclofenac—ABCC1—adipose tissue—polycystic ovary syndrome	0.000865	0.00529	CbGeAlD
Diclofenac—ABCC4—female gonad—polycystic ovary syndrome	0.000849	0.00519	CbGeAlD
Diclofenac—Oedema—Metformin—polycystic ovary syndrome	0.000841	0.00662	CcSEcCtD
Diclofenac—Infection—Metformin—polycystic ovary syndrome	0.000836	0.00658	CcSEcCtD
Diclofenac—Clonidine—ADRA1A—polycystic ovary syndrome	0.00083	0.059	CrCbGaD
Diclofenac—Shock—Metformin—polycystic ovary syndrome	0.000827	0.00652	CcSEcCtD
Diclofenac—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000825	0.0065	CcSEcCtD
Diclofenac—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000823	0.00649	CcSEcCtD
Diclofenac—CYP2B6—adrenal cortex—polycystic ovary syndrome	0.000821	0.00502	CbGeAlD
Diclofenac—CYP2C8—endometrium—polycystic ovary syndrome	0.000817	0.005	CbGeAlD
Diclofenac—Skin disorder—Metformin—polycystic ovary syndrome	0.000817	0.00643	CcSEcCtD
Diclofenac—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000813	0.0064	CcSEcCtD
Diclofenac—Anorexia—Metformin—polycystic ovary syndrome	0.000802	0.00631	CcSEcCtD
Diclofenac—ABCC4—endocrine gland—polycystic ovary syndrome	0.000789	0.00483	CbGeAlD
Diclofenac—Hypotension—Metformin—polycystic ovary syndrome	0.000786	0.00619	CcSEcCtD
Diclofenac—ABCC1—adrenal gland—polycystic ovary syndrome	0.000776	0.00475	CbGeAlD
Diclofenac—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000766	0.00604	CcSEcCtD
Diclofenac—Paraesthesia—Metformin—polycystic ovary syndrome	0.000755	0.00595	CcSEcCtD
Diclofenac—Dyspnoea—Metformin—polycystic ovary syndrome	0.00075	0.00591	CcSEcCtD
Diclofenac—Somnolence—Metformin—polycystic ovary syndrome	0.000748	0.00589	CcSEcCtD
Diclofenac—Dyspepsia—Metformin—polycystic ovary syndrome	0.00074	0.00583	CcSEcCtD
Diclofenac—CYP2C8—pituitary gland—polycystic ovary syndrome	0.00074	0.00453	CbGeAlD
Diclofenac—Decreased appetite—Metformin—polycystic ovary syndrome	0.000731	0.00576	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000726	0.00572	CcSEcCtD
Diclofenac—Fatigue—Metformin—polycystic ovary syndrome	0.000725	0.00571	CcSEcCtD
Diclofenac—ABCC1—female gonad—polycystic ovary syndrome	0.000724	0.00443	CbGeAlD
Diclofenac—Constipation—Metformin—polycystic ovary syndrome	0.000719	0.00566	CcSEcCtD
Diclofenac—ABCC1—vagina—polycystic ovary syndrome	0.000719	0.0044	CbGeAlD
Diclofenac—PTGS2—adrenal cortex—polycystic ovary syndrome	0.000709	0.00434	CbGeAlD
Diclofenac—CYP2C19—vagina—polycystic ovary syndrome	0.000702	0.00429	CbGeAlD
Diclofenac—CYP1A1—uterus—polycystic ovary syndrome	0.000695	0.00425	CbGeAlD
Diclofenac—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000693	0.00546	CcSEcCtD
Diclofenac—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000688	0.00542	CcSEcCtD
Diclofenac—CYP1A1—adipose tissue—polycystic ovary syndrome	0.00068	0.00416	CbGeAlD
Diclofenac—Urticaria—Metformin—polycystic ovary syndrome	0.000668	0.00526	CcSEcCtD
Diclofenac—Abdominal pain—Metformin—polycystic ovary syndrome	0.000665	0.00524	CcSEcCtD
Diclofenac—PTGS1—endometrium—polycystic ovary syndrome	0.000663	0.00406	CbGeAlD
Diclofenac—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000656	0.00402	CbGeAlD
Diclofenac—PTGS2—endometrium—polycystic ovary syndrome	0.000634	0.00388	CbGeAlD
Diclofenac—CYP2C8—vagina—polycystic ovary syndrome	0.000612	0.00375	CbGeAlD
Diclofenac—PTGS1—uterus—polycystic ovary syndrome	0.000611	0.00374	CbGeAlD
Diclofenac—Asthenia—Metformin—polycystic ovary syndrome	0.000603	0.00475	CcSEcCtD
Diclofenac—PTGS1—pituitary gland—polycystic ovary syndrome	0.0006	0.00367	CbGeAlD
Diclofenac—PTGS1—adipose tissue—polycystic ovary syndrome	0.000597	0.00366	CbGeAlD
Diclofenac—Pruritus—Metformin—polycystic ovary syndrome	0.000595	0.00469	CcSEcCtD
Diclofenac—CYP2B6—adrenal gland—polycystic ovary syndrome	0.000593	0.00363	CbGeAlD
Diclofenac—PTGS2—uterus—polycystic ovary syndrome	0.000584	0.00357	CbGeAlD
Diclofenac—Diarrhoea—Metformin—polycystic ovary syndrome	0.000575	0.00453	CcSEcCtD
Diclofenac—PTGS2—pituitary gland—polycystic ovary syndrome	0.000573	0.00351	CbGeAlD
Diclofenac—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000573	0.00351	CbGeAlD
Diclofenac—PTGS2—adipose tissue—polycystic ovary syndrome	0.000571	0.00349	CbGeAlD
Diclofenac—CYP1A1—female gonad—polycystic ovary syndrome	0.000569	0.00348	CbGeAlD
Diclofenac—CYP1A1—vagina—polycystic ovary syndrome	0.000565	0.00346	CbGeAlD
Diclofenac—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000556	0.0034	CbGeAlD
Diclofenac—Dizziness—Metformin—polycystic ovary syndrome	0.000556	0.00438	CcSEcCtD
Diclofenac—CYP2B6—vagina—polycystic ovary syndrome	0.000549	0.00336	CbGeAlD
Diclofenac—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000536	0.00328	CbGeAlD
Diclofenac—PTGS1—adrenal gland—polycystic ovary syndrome	0.000536	0.00328	CbGeAlD
Diclofenac—ABCB1—embryo—polycystic ovary syndrome	0.000536	0.00328	CbGeAlD
Diclofenac—Vomiting—Metformin—polycystic ovary syndrome	0.000535	0.00421	CcSEcCtD
Diclofenac—Rash—Metformin—polycystic ovary syndrome	0.00053	0.00418	CcSEcCtD
Diclofenac—Dermatitis—Metformin—polycystic ovary syndrome	0.00053	0.00417	CcSEcCtD
Diclofenac—CYP1A1—endocrine gland—polycystic ovary syndrome	0.000529	0.00324	CbGeAlD
Diclofenac—Headache—Metformin—polycystic ovary syndrome	0.000527	0.00415	CcSEcCtD
Diclofenac—CYP2B6—endocrine gland—polycystic ovary syndrome	0.000514	0.00314	CbGeAlD
Diclofenac—PTGS2—adrenal gland—polycystic ovary syndrome	0.000512	0.00313	CbGeAlD
Diclofenac—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000509	0.00311	CbGeAlD
Diclofenac—PTGS1—female gonad—polycystic ovary syndrome	0.0005	0.00306	CbGeAlD
Diclofenac—Nausea—Metformin—polycystic ovary syndrome	0.0005	0.00393	CcSEcCtD
Diclofenac—PTGS1—vagina—polycystic ovary syndrome	0.000497	0.00304	CbGeAlD
Diclofenac—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000482	0.00295	CbGeAlD
Diclofenac—PTGS2—female gonad—polycystic ovary syndrome	0.000478	0.00292	CbGeAlD
Diclofenac—PTGS2—vagina—polycystic ovary syndrome	0.000475	0.0029	CbGeAlD
Diclofenac—PTGS1—endocrine gland—polycystic ovary syndrome	0.000465	0.00284	CbGeAlD
Diclofenac—PTGS2—endocrine gland—polycystic ovary syndrome	0.000444	0.00272	CbGeAlD
Diclofenac—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000439	0.00269	CbGeAlD
Diclofenac—Clonidine—CYP1A1—polycystic ovary syndrome	0.000423	0.0301	CrCbGaD
Diclofenac—ABCB1—endometrium—polycystic ovary syndrome	0.000392	0.0024	CbGeAlD
Diclofenac—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000388	0.00237	CbGeAlD
Diclofenac—ABCB1—uterus—polycystic ovary syndrome	0.000361	0.00221	CbGeAlD
Diclofenac—ABCB1—pituitary gland—polycystic ovary syndrome	0.000355	0.00217	CbGeAlD
Diclofenac—ABCB1—adipose tissue—polycystic ovary syndrome	0.000353	0.00216	CbGeAlD
Diclofenac—ABCB1—adrenal gland—polycystic ovary syndrome	0.000317	0.00194	CbGeAlD
Diclofenac—ABCB1—female gonad—polycystic ovary syndrome	0.000295	0.00181	CbGeAlD
Diclofenac—ABCB1—vagina—polycystic ovary syndrome	0.000294	0.0018	CbGeAlD
Diclofenac—ABCB1—endocrine gland—polycystic ovary syndrome	0.000275	0.00168	CbGeAlD
Diclofenac—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.3e-05	4.86e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP17A1—polycystic ovary syndrome	1.29e-05	4.84e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.29e-05	4.84e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PRL—polycystic ovary syndrome	1.29e-05	4.83e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	1.29e-05	4.83e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	1.29e-05	4.82e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	1.29e-05	4.82e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CYP11A1—polycystic ovary syndrome	1.28e-05	4.81e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—RRM2—polycystic ovary syndrome	1.28e-05	4.79e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	1.28e-05	4.79e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.28e-05	4.78e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.27e-05	4.77e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IRS1—polycystic ovary syndrome	1.27e-05	4.75e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PPARG—polycystic ovary syndrome	1.27e-05	4.75e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	1.27e-05	4.74e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.26e-05	4.71e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—POMC—polycystic ovary syndrome	1.25e-05	4.68e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—INS—polycystic ovary syndrome	1.24e-05	4.66e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	1.24e-05	4.65e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	1.24e-05	4.65e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—MTHFR—polycystic ovary syndrome	1.24e-05	4.63e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—YAP1—polycystic ovary syndrome	1.23e-05	4.62e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	1.23e-05	4.62e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—IGF1—polycystic ovary syndrome	1.23e-05	4.6e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT2—polycystic ovary syndrome	1.23e-05	4.59e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—POMC—polycystic ovary syndrome	1.22e-05	4.57e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	1.22e-05	4.57e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	1.22e-05	4.56e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—INS—polycystic ovary syndrome	1.21e-05	4.55e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	1.21e-05	4.54e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKR1C3—polycystic ovary syndrome	1.21e-05	4.54e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—INS—polycystic ovary syndrome	1.21e-05	4.53e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	1.2e-05	4.48e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CYP17A1—polycystic ovary syndrome	1.19e-05	4.47e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	1.19e-05	4.46e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	1.19e-05	4.46e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	1.19e-05	4.44e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NAMPT—polycystic ovary syndrome	1.18e-05	4.44e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.18e-05	4.44e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IRS1—polycystic ovary syndrome	1.18e-05	4.43e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.18e-05	4.41e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	1.18e-05	4.41e-05	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—IL6—polycystic ovary syndrome	1.17e-05	4.4e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	1.17e-05	4.4e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IGF1—polycystic ovary syndrome	1.17e-05	4.4e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT2—polycystic ovary syndrome	1.17e-05	4.4e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	1.17e-05	4.38e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.17e-05	4.38e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1.17e-05	4.37e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	1.17e-05	4.37e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—TH—polycystic ovary syndrome	1.16e-05	4.36e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	1.16e-05	4.36e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.16e-05	4.35e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	1.16e-05	4.34e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	1.15e-05	4.31e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	1.15e-05	4.3e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—VEGFA—polycystic ovary syndrome	1.14e-05	4.28e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	1.14e-05	4.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—SLC2A4—polycystic ovary syndrome	1.13e-05	4.24e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—INS—polycystic ovary syndrome	1.13e-05	4.24e-05	CbGpPWpGaD
Diclofenac—TTR—Disease—IL6—polycystic ovary syndrome	1.13e-05	4.23e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	1.12e-05	4.2e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—TH—polycystic ovary syndrome	1.12e-05	4.19e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SERPINE1—polycystic ovary syndrome	1.11e-05	4.18e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	1.11e-05	4.16e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	1.11e-05	4.15e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	1.11e-05	4.15e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	1.1e-05	4.14e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—TH—polycystic ovary syndrome	1.09e-05	4.1e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	1.09e-05	4.1e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT2—polycystic ovary syndrome	1.09e-05	4.1e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	1.09e-05	4.08e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	1.09e-05	4.07e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—SLC2A4—polycystic ovary syndrome	1.09e-05	4.07e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	1.08e-05	4.05e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	1.08e-05	4.05e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	1.08e-05	4.05e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NCOR1—polycystic ovary syndrome	1.08e-05	4.05e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	1.07e-05	3.99e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CYP19A1—polycystic ovary syndrome	1.06e-05	3.99e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	1.06e-05	3.98e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	1.06e-05	3.97e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRG1—polycystic ovary syndrome	1.06e-05	3.97e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.06e-05	3.96e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	1.06e-05	3.95e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	1.05e-05	3.93e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	1.05e-05	3.92e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.04e-05	3.91e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	1.04e-05	3.89e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	1.04e-05	3.89e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	1.04e-05	3.88e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—TH—polycystic ovary syndrome	1.03e-05	3.87e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	1.02e-05	3.84e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP19A1—polycystic ovary syndrome	1.02e-05	3.83e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	1.01e-05	3.78e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	1.01e-05	3.77e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—SLC2A4—polycystic ovary syndrome	1e-05	3.76e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	1e-05	3.76e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PPARG—polycystic ovary syndrome	1e-05	3.75e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	1e-05	3.75e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	9.92e-06	3.72e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—POMC—polycystic ovary syndrome	9.88e-06	3.7e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—INS—polycystic ovary syndrome	9.82e-06	3.68e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	9.76e-06	3.66e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	9.7e-06	3.63e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	9.68e-06	3.63e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	9.66e-06	3.62e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.64e-06	3.61e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	9.58e-06	3.59e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MTHFR—polycystic ovary syndrome	9.55e-06	3.58e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	9.53e-06	3.57e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—POMC—polycystic ovary syndrome	9.53e-06	3.57e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.51e-06	3.56e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GNAS—polycystic ovary syndrome	9.5e-06	3.56e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—INS—polycystic ovary syndrome	9.47e-06	3.55e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—TH—polycystic ovary syndrome	9.46e-06	3.55e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—CYP19A1—polycystic ovary syndrome	9.44e-06	3.54e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—TH—polycystic ovary syndrome	9.41e-06	3.53e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	9.41e-06	3.52e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	9.24e-06	3.46e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	9.21e-06	3.45e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	9.15e-06	3.43e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GNAS—polycystic ovary syndrome	9.13e-06	3.42e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IRS2—polycystic ovary syndrome	9.08e-06	3.4e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—NCOR1—polycystic ovary syndrome	9.05e-06	3.39e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	9.04e-06	3.39e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—IL6—polycystic ovary syndrome	8.98e-06	3.36e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	8.97e-06	3.36e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	8.95e-06	3.35e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	8.94e-06	3.35e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	8.9e-06	3.34e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—NCOR1—polycystic ovary syndrome	8.69e-06	3.26e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	8.66e-06	3.24e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	8.62e-06	3.23e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	8.61e-06	3.22e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CYP1A1—polycystic ovary syndrome	8.57e-06	3.21e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	8.51e-06	3.19e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—TH—polycystic ovary syndrome	8.45e-06	3.17e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GNAS—polycystic ovary syndrome	8.43e-06	3.16e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	8.29e-06	3.1e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TH—polycystic ovary syndrome	8.25e-06	3.09e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP1A1—polycystic ovary syndrome	8.24e-06	3.09e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.24e-06	3.09e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	8.22e-06	3.08e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	8.18e-06	3.07e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	8.18e-06	3.07e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	8.17e-06	3.06e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.12e-06	3.04e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	8.07e-06	3.02e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—POMC—polycystic ovary syndrome	8.05e-06	3.02e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—NCOR1—polycystic ovary syndrome	8.03e-06	3.01e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	8.02e-06	3.01e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	8.02e-06	3e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—INS—polycystic ovary syndrome	8.01e-06	3e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	8e-06	3e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—MTHFR—polycystic ovary syndrome	7.99e-06	3e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IRS1—polycystic ovary syndrome	7.93e-06	2.97e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—polycystic ovary syndrome	7.91e-06	2.96e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	7.75e-06	2.9e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	7.73e-06	2.9e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	7.73e-06	2.89e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	7.73e-06	2.89e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TH—polycystic ovary syndrome	7.7e-06	2.89e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—MTHFR—polycystic ovary syndrome	7.68e-06	2.88e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GNAS—polycystic ovary syndrome	7.68e-06	2.88e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—polycystic ovary syndrome	7.67e-06	2.87e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	7.61e-06	2.85e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—INS—polycystic ovary syndrome	7.59e-06	2.84e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	7.54e-06	2.83e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	7.53e-06	2.82e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	7.49e-06	2.81e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	7.36e-06	2.76e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT2—polycystic ovary syndrome	7.34e-06	2.75e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—NCOR1—polycystic ovary syndrome	7.32e-06	2.74e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	7.13e-06	2.67e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—MTHFR—polycystic ovary syndrome	7.09e-06	2.66e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	7.04e-06	2.64e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	6.98e-06	2.61e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SERPINE1—polycystic ovary syndrome	6.97e-06	2.61e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	6.94e-06	2.6e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	6.9e-06	2.59e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	6.9e-06	2.58e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	6.73e-06	2.52e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	6.66e-06	2.49e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TH—polycystic ovary syndrome	6.58e-06	2.47e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	6.57e-06	2.46e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	6.5e-06	2.44e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARG—polycystic ovary syndrome	6.48e-06	2.43e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—MTHFR—polycystic ovary syndrome	6.47e-06	2.42e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	6.41e-06	2.4e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	6.4e-06	2.4e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	6.39e-06	2.4e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—POMC—polycystic ovary syndrome	6.39e-06	2.4e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—INS—polycystic ovary syndrome	6.36e-06	2.38e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	6.32e-06	2.37e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	6.29e-06	2.36e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARG—polycystic ovary syndrome	6.23e-06	2.33e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	6.23e-06	2.33e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—POMC—polycystic ovary syndrome	6.14e-06	2.3e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—INS—polycystic ovary syndrome	6.11e-06	2.29e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	6.1e-06	2.29e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	6.08e-06	2.28e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	6.02e-06	2.26e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	6.02e-06	2.26e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	5.99e-06	2.24e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—INS—polycystic ovary syndrome	5.99e-06	2.24e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.96e-06	2.23e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.87e-06	2.2e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	5.81e-06	2.18e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARG—polycystic ovary syndrome	5.75e-06	2.16e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	5.68e-06	2.13e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—POMC—polycystic ovary syndrome	5.67e-06	2.13e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	5.67e-06	2.12e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—INS—polycystic ovary syndrome	5.64e-06	2.11e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	5.37e-06	2.01e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—polycystic ovary syndrome	5.3e-06	1.99e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	5.29e-06	1.98e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	5.27e-06	1.98e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARG—polycystic ovary syndrome	5.24e-06	1.97e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	5.2e-06	1.95e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—INS—polycystic ovary syndrome	5.17e-06	1.94e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—POMC—polycystic ovary syndrome	5.17e-06	1.94e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—INS—polycystic ovary syndrome	5.14e-06	1.93e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	5.12e-06	1.92e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.08e-06	1.9e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—polycystic ovary syndrome	4.94e-06	1.85e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.94e-06	1.85e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	4.85e-06	1.82e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	4.71e-06	1.76e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	4.65e-06	1.74e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	4.64e-06	1.74e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—INS—polycystic ovary syndrome	4.62e-06	1.73e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	4.6e-06	1.72e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—POMC—polycystic ovary syndrome	4.53e-06	1.7e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	4.52e-06	1.7e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—INS—polycystic ovary syndrome	4.51e-06	1.69e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	4.29e-06	1.61e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	4.23e-06	1.59e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—INS—polycystic ovary syndrome	4.21e-06	1.58e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.15e-06	1.55e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.95e-06	1.48e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.75e-06	1.4e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	3.67e-06	1.37e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	3.62e-06	1.36e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—INS—polycystic ovary syndrome	3.6e-06	1.35e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3.49e-06	1.31e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—polycystic ovary syndrome	3.32e-06	1.24e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.83e-06	1.06e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.79e-06	1.05e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.78e-06	1.04e-05	CbGpPWpGaD
